SNNのニュース
Prolocor Announces Appointment of Edward L. Rosen to Its Board of Directors 2023/03/09 14:00:00 Accesswire
PHILADELPHIA, PA / ACCESSWIRE / March 9, 2023 / Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the potential to predict the risk of thrombosis by quantifying FcγRIIa on the surface of platelets, today announced that Edward L. Rosen has joined the company''s Board of Directors. Rosen is a highly accomplished and well-respected industry expert and has held numerous senior-level positions during his illustrious career. Prolocor Logo Prolocor Logo Most recently, Rosen served as Chief Strategy & Commercial Officer at Clinical Genomics, where he generated and implemented an integrated commercial strategy, delivered successful IP licensing, and oversaw efforts that gained Medicare and Medicare Advantage reimbursement coverage. Prior to joining Clinical Genomics, he served as Executive-in-Residence at Columbia University (Office of Technology Ventures), where he collaborated with entrepreneurs and inventors to facilitate the transfer of research innovations from the lab to the market, as well as supporting start-up efforts across therapeutic, diagnostic and device applications.
Smith & Nephew plc: Smith+Nephew''s VISIONAIRE Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation 2023/03/06 13:06:00 Finanz Nachrichten
LONDON, March 6, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a systemic literature review and meta-analysis1 of its VISIONAIRE Pati…
Smith+Nephew''s VISIONAIRE Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation 2023/03/06 13:00:00 PR Newswire
LONDON, March 6, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a systemic literature review and meta-analysis1 of its VISIONAIRE Patient-Specific Instrumentation (PSI) showing that its use leads to improvements in alignment…
Laparoscopic Devices Market Size And Forecast - 2022 to 2030 | DEAM, ConMed Corporation, Medtronic Plc, Smith & Nephew Plc, Richard Wolf GmbH 2023/02/24 12:40:59 OpenPR
Newark, New Castle, USA: Growth Plus Reports recently introduced a new title on Laparoscopic Devices Market 2022 and forecast 2030 from its database. The Laparoscopic Devices report provides a study with an in-depth overview, describing the product/industry scope and elaborates
Smith & Nephew: Flat FY22 Growth, Now An Execution Story (NYSE:SNN) 2023/02/22 19:43:00 Seeking Alpha
Smith & Nephew saw flat top-line growth, declines in earnings and CFFO relative to FY21. Click here to read my most recent analysis of SNN stock.
Will Investors Notice Exciting Sign On Smith & Nephew''s Chart? 2023/01/30 14:47:56 Benzinga
If history is any guide, there may be good fortune ahead for shares of Smith & Nephew (NYSE: SNN ). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions. When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending … Full story available on Benzinga.com
Smith+Nephew receives Innovative Technology designation from Vizient for LEAF™ Patient Monitoring System 2023/01/30 13:00:00 PR Newswire
Designation recognizes Vizient-contracted products that bring improvements to healthcare industry LONDON, Jan. 30, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its LEAF Patient Monitoring System has received an…
Pressure Ulcers Treatment Market to See Booming Growth 2023-2030 | Smith & Nephew PLC, Coloplast Group, ConvaTec Group PLC, B. Braun Melsungen AG 2023/01/30 10:31:42 OpenPR
Edition: 2023 The Global Pressure Ulcers Treatment Market Report provides In-depth analysis on the market status of the Pressure Ulcers Treatment Top manufacturers with best facts and figures, meaning, Definition, SWOT and PESTEL analysis, expert opinions and the latest developments across
Minimally Invasive Surgery Global Market Report 2022: Ukraine-Russia War Impact 2022/12/20 11:27:00 GlobeNewswire
Major players in the minimally invasive surgery market are Arthrex, B. Braun, Intuitive, Medtronic Inc, OmniGuide Inc , Eximis Surgical Inc, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Inc, NuVasive Inc, Fortimedix Surgical BV, Microline Surgical Inc, Cirtec Medical Corp, Johnson & Johnson Services Inc, Philips Healthcare, TransEnterix , Silex Medical LLC and Freudenberg Medical. Major players in the minimally invasive surgery market are Arthrex, B. Braun, Intuitive, Medtronic Inc, OmniGuide Inc , Eximis Surgical Inc, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Inc, NuVasive Inc, Fortimedix Surgical BV, Microline Surgical Inc, Cirtec Medical Corp, Johnson & Johnson Services Inc, Philips Healthcare, TransEnterix , Silex Medical LLC and Freudenberg Medical.
Digital Wound Measurement Devices Market to Witness Huge Growth by Key Players: Hitachi Ltd, Wound Zoom Inc, ARANZ Medical Ltd, eKare Inc, Smith & Nephew 2022/12/16 09:01:57 OpenPR
According to Market Study Report, Digital Wound Measurement Devices Market provides a comprehensive analysis of the Digital Wound Measurement Devices Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data
Smith & Nephew plc (SNN) CEO Deepak Nath on Q2 2022 Results - Earnings Call Transcript 2022/07/29 22:04:06 Seeking Alpha
Smith & Nephew plc (NYSE:NYSE:SNN) Q2 2022 Results Conference Call July 28, 2022 03:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief…
Smith & Nephew Shares Fall On Lower Margins As Cost Headwinds Hit Q2 Profit 2022/07/28 19:30:06 Benzinga
Smith & Nephew Plc (NYSE: SNN ) reported Q2 revenue of $1.29 billion , up 1.2% on an underlying basis but down 3.1% on a reported basis, including a 430 basis point foreign exchange headwind. Orthopedics revenue declined 1.1%, or by 4.9% on a reported basis, reflecting execution and supply chain challenges. Sports Medicine and ENT were up 1.9%, but down 2.4% on a reported basis, with growth … Full story available on Benzinga.com
Canaccord Genuity Downgrades Smith & Nephew to Hold 2022/07/28 14:28:01 Investing.com
https://www.investing.com/news/pro/canaccord-genuity-downgrades-smith--nephew-to-hold-432SI-2856978
Smith & Nephew Non-GAAP EPS of 38.10c, revenue of $2.6B misses by $30M 2022/07/28 12:00:40 Seeking Alpha
Smith & Nephew press release (SNN): 1H Non-GAAP EPS of 38.10c.Revenue of $2.6B (flat Y/Y) misses by $30M.2022 Full Year Outlook● Unchanged full-year underlying revenue growth guidance…
Smith+Nephew Q2 Revenue, H1 Profit Down; Backs FY22 Sales View; Stock Dips 2022/07/28 08:52:00 Finanz Nachrichten
LONDON (dpa-AFX) - Shares of Smith & Nephew Plc (SN, SNN) were losing around 10 percent in the morning trading in London after the medical technology company reported Thursday weak revenues in its…